Oct 6, 2023 | Case Study, Company News
Executive Summary Exom, a digital-first contract research organization (CRO), worked with AWS Partner Storm Reply to build a reliable and compliant chatbot using artificial intelligence (AI) on Amazon Web Services (AWS). The solution guides remote participants using...
Mar 20, 2023 | Clinical Trial News, Company News, Uncategorized
Europe’s research and innovation funding programme Horizon2020 has granted research teams 8M euro funding for developing new effective therapies for rare diseases. Exom Group is proud to be a member of this consortium, called GEREMY. This project aims to find a...
Nov 14, 2022 | Company News, Genius Engage, Genius Suite
Genius vENGAGE: The Remote Verbal Consent for a Patient-Centric Clinical Trial Exom Group, a Clinscience company, is proud to announce the release of the first patient-centric “reliable & compliant” remote verbal consent for clinical trials (Genius vENGAGE). The...
Jul 14, 2022 | Clinical Trial News, Company News
ASCO Annual Meeting 2022 During the first week of June, we witnessed the opening of the annual meeting of the American Society of Clinical Oncology (ASCO) for the first time since 2019. ASCO is known as the world’s leading Oncology event that brings together...
May 11, 2022 | Clinical Trial News, Company News
The Global CRO pursues further development in the digitalization of Clinical Research Clinscience US LLC, a subsidiary of Neuca Group, on 26th of April signed an investment agreement to acquire 51% of shares in Agati Systems. The US-based (Texas) Company, together...
Jan 15, 2022 | Company News, Genius Suite
Exom is proud to announce to being awarded the GHP Global Excellence Award by Global Health & Pharma as “Most Innovative Full-Service CRO – 2022” for our pioneering and cutting-edge use of technology (with our Genius SUITE™) in clinical trials to...
